加载中
NASDAQBasic MaterialsChemicals - Specialty
最新数据
US$2.65
−US$0.18 · -6.36%
ASP Isotopes Inc. is an emerging advanced materials company, currently in its pre-commercial stage. This firm is dedicated to the comprehensive management of isotopes, encompassing their creation, dissemination, promotion, and eventual sale. The company's developmental portfolio includes Molybdenum-100, a non-radioactive isotope designed for medical applications, alongside Carbon-14 and Silicon-28. Furthermore, ASP Isotopes is involved with Uranium-235, a specific uranium isotope considered crucial for the carbon-free energy sector. Established in 2021, the company maintains its headquarters in Boca Raton, Florida.
前收盘价
US$2.65
−US$0.18 · -6.36%
盘中时间采用ET。市场数据可能有所延迟。
ASP Isotopes Inc. is an emerging advanced materials company, currently in its pre-commercial stage. This firm is dedicated to the comprehensive management of isotopes, encompassing their creation, dissemination, promotion, and eventual sale. The company's developmental portfolio includes Molybdenum-100, a non-radioactive isotope designed for medical applications, alongside Carbon-14 and Silicon-28. Furthermore, ASP Isotopes is involved with Uranium-235, a specific uranium isotope considered crucial for the carbon-free energy sector. Established in 2021, the company maintains its headquarters in Boca Raton, Florida.
日内区间
当前US$2.65
52周区间
当前US$2.65
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
卖出
估值
46
合理估值
情绪
38
看跌
风险
88
极高风险
动量
21
动能减弱
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
ASP Isotopes Inc. is an emerging advanced materials company, currently in its pre-commercial stage. This firm is dedicated to the comprehensive management of isotopes, encompassing their creation, dissemination, promotion, and eventual sale. The company's developmental portfolio includes Molybdenum-100, a non-radioactive isotope designed for medical applications, alongside Carbon-14 and Silicon-28. Furthermore, ASP Isotopes is involved with Uranium-235, a specific uranium isotope considered crucial for the carbon-free energy sector. Established in 2021, the company maintains its headquarters in Boca Raton, Florida.
日内区间
当前US$2.65
52周区间
当前US$2.65
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 2384.9万 USD | 414.4万 USD | 43.3万 USD | — | — |
| 销货成本 | 2044.4万 USD | 254.5万 USD | 29.41万 USD | — | 1.94万 USD |
| 毛利 | 340.5万 USD | 159.9万 USD | 13.9万 USD | — | −1.94万 USD |
| 研究与开发 | 1235.8万 USD | 313.9万 USD | 76.46万 USD | 127.35万 USD | 4.16万 USD |
| 销售、一般及管理费用 | 4823.8万 USD | 2481.4万 USD | 1541.64万 USD | 382.55万 USD | 254.71万 USD |
| 营业费用 | 6059.6万 USD | 2795.3万 USD | 1618.1万 USD | 509.9万 USD | 258.87万 USD |
| 利息收入 | 679万 USD | 123.87万 USD | 9074 USD | 3382 USD | 115 USD |
| 利息支出 | 57.5万 USD | 25.89万 USD | 11.85万 USD | — | — |
| 折旧和摊销 | 191.2万 USD | 47.14万 USD | 3.74万 USD | 7.26万 USD | 1.94万 USD |
| 营业利润 | −5719.1万 USD | −2635.4万 USD | −1604.2万 USD | −509.9万 USD | −260.8万 USD |
| 净利润 | −1.75亿 USD | −3233.4万 USD | −1628.62万 USD | −494.51万 USD | −260.79万 USD |
公司数据更新于 2026年10月11日。
近期已公布业绩
近期已公布业绩
报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI1444.75万0.00%2.3万亿 USD0.03%US$381.94+0.63%
iShares Russell 2000 ETFIWM1043.66万0.01%787.4亿 USD0.19%US$278.94+0.49%
Vanguard Extended Market ETFVXF516.79万0.01%954亿 USD0.05%US$235+0.80%
American Beacon GLG Natural Resources ETFMGNR350.32万0.28%12.56亿 USD0.75%US$49.77+0.91%
iShares Russell 2000 Growth ETFIWO312.42万0.02%139.17亿 USD0.24%US$356.78+0.94%
Vanguard Russell 2000 ETFVTWO269.12万0.01%180亿 USD0.06%US$112.66+0.50%
Range Nuclear Renaissance Index ETFNUKZ221.85万0.33%6.76亿 USD0.85%US$61.26+0.92%
Schwab U.S. Small-Cap ETFSCHA204.42万0.01%218.24亿 USD0.03%US$32.79+0.40%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFAmerican Beacon GLG Natural Resources ETFMGNRiShares Russell 2000 Growth ETFIWOVanguard Russell 2000 ETFVTWORange Nuclear Renaissance Index ETFNUKZSchwab U.S. Small-Cap ETFSCHAAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
